Report Company Directory

Krynica Vitamin

• Krynica Vitamin Sa: 1 director by SmartInsider
• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Feasibility Study Results in December to be a Catalyst for this Junior by Fundamental Research
• Strategy 2020: Get ready to catch the wave... The FLOW wave by Trigon Brokerage House
• Quarterly review: Update of recommendations and 3Q19 results forecast by Trigon Brokerage House
• Quarterly review: Update of recommendations and 1Q19 results forecast by Trigon Brokerage House
• Quarterly review: Update of recommendations and 2Q19 results forecast by Trigon Brokerage House
• Quarterly review: Update of recommendations and 1Q19 results forecast by Trigon Brokerage House
• Strategy 2019 by Trigon Brokerage House
• Quarterly review: recommendations update and forecasts for 3Q18 by Trigon Brokerage House

Krynicki Recykling SA

• Krynicki Recykling S.A.: 1 director by SmartInsider
• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Feasibility Study Results in December to be a Catalyst for this Junior by Fundamental Research
• Ford Equity International Rating and Forecast Report by Ford Equity Research

Krypton Industries

• Ford Equity International Rating and Forecast Report by Ford Equity Research

Krystal Biotech Inc

• Fast Forward No. 768 by William Blair
• Second-Quarter Earnings: U.S. Vyjuvek Revenue Expected to Be Lower in Third Quarter but Will Be Partly Offset by EU Launch by William Blair
• Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results by GlobeNewsWire
• Fast Forward No. 767 by William Blair
• CBER Leadership to Change Hands Again as Vinay Prasad, M.D., Departs FDA by William Blair
• Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025 by GlobeNewsWire
• Arialys Therapeutics: Our Q&A With Management by William Blair
• Fast Forward No. 766 by William Blair
• Vyjuvek Granted Marketing Authorization in Japan; Commercial Launch Expected by Year-End by William Blair
• Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa by GlobeNewsWire

KRYSTAL INTEGRATED SERVICES LIMITED